PEStore

Buyout PE

Patient Square Capital

Patient Square Capital acquires controlling stakes in established, profitable businesses, from United States. It states a focus on financial services and healthcare & life sciences.

Disclosed holdings25
Earliest stated investment2025
HeadquartersUnited States
Largest single fundNot stated

Regulatory record

How Patient Square Capital is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusSEC registered
Regulatory assets under management$18bn
Employees97
Private funds advised30 · $17bn gross
SEC adviser numberCRD 312203

Portfolio

Disclosed holdings

Companies Patient Square Capital lists on its own website. 2 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Premier20251
Paradigm20260
Access Telecare
Apollo Therapeutics
Chenmed
Companies Linkedin Home About Team You
Corrohealth
Elevage Medical Technologies
Enavate Sciences
Gondolabio
Hanger
Kriya Therapeutics
Lxe Hearing
Osanni Bio
Patterson
Radius Health
Resolve Biosciences
Site
Striving
Summit Bhc
Syneos Health
Therefore
These
UK Website Policy Website Policy Important Legal Information
Use

Compiled from Patient Square Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Recorded transactions

Buying and selling

Deals in which Patient Square Capital is named as buyer or seller in the transaction archive. 1 recorded acquisition.

CompanySideCounterpartyYearConsideration
Radius HealthBought2022$890m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Financial Services

What companies have actually sold for in financial services, across 726 recorded transactions.

Median consideration$107m
Middle 50%$35m-$267m
Revenue multiple3.6×
EBITDA multiple9.55×

The full financial services picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a financial services business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Patient Square Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in financial services.